Clicky

Wednesday, November 4, 2026

Breaking News

Latest SEC filings as they come in

S&P Global's Twomey Reports Stock Transactions in SEC Filing

Christina Twomey of S&P Global disclosed stock transactions in a recent SEC filing, highlighting her ongoing equity involvement and compliance.

Krantz Jason Ronald acquires 12,166 shares of stock

Krantz Jason Ronald acquires 12,166 shares of Definitive Healthcare Corp., signaling confidence in the prepackaged software services sector.

Generac director acquires shares in recent transaction

Generac Holdings Inc. director Andrew Lampereur acquires 159 shares at $197.30 each, reflecting ongoing insider activity in the motors and generators sector.

Heller Casey reports share transaction for tax obligations

Heller Casey, CFO of Definitive Healthcare, reports share transaction involving tax obligations, highlighting trends in executive compensation in software services.

Grosfield Howard Exercises Stock Options at American Express

Grosfield Howard exercises stock options, increasing his stake in American Express, reflecting executive confidence in the finance services sector.

Artiva CEO Aslan Fred Sells Shares to Cover Tax Obligations

CEO Aslan Fred of Artiva Biotherapeutics sold shares to meet tax obligations, highlighting trends in executive compensation within the biotechnology sector.

Clement David P sells 4,800 shares of Vulcan Materials stock

Clement David P, SVP of Vulcan Materials, sold 4,800 shares of common stock, reflecting strategic management activity in the mining sector.

UnitedHealth Group Reports Strong Q3 Results Amid Growth

UnitedHealth Group's Q3 results show revenue growth and increased membership, reinforcing its leadership in the hospital and medical service plans sector.

Sixth Street Specialty Lending reports strong Q3 results

Sixth Street Specialty Lending, Inc. announces its Q3 financial results, showcasing growth and stability in the specialty lending sector.

Banerjee Subhashis sells shares to cover tax obligations

Banerjee Subhashis, CMO of Artiva Biotherapeutics, sells shares to meet tax obligations, reflecting executive activity in the life sciences sector.

SLM Corp CFO Graham Peter M Reports Stock Transaction

Graham Peter M, CFO of SLM Corp, disclosed a stock transaction involving over 10,000 shares, emphasizing the company's executive compensation strategy.

Versant Media Group reports third-quarter results for 2026

Versant Media Group, Inc. shares its third-quarter results for 2026, highlighting growth in the television broadcasting sector amid industry changes.

Vertex Pharmaceuticals Reports Q3 2026 Financial Results

Vertex Pharmaceuticals has filed its Q3 2026 report, detailing significant financial metrics and ongoing projects in the pharmaceutical sector.

Transcat Inc. reports quarterly results, shows industry strength

Transcat Inc. has released its quarterly report, showcasing its performance in the measurement instruments sector and highlighting growth potential.

Sotera Health reports Q3 results, outlines future strategies

Sotera Health Co releases its Q3 financial results, detailing growth strategies and operational updates that impact the health services industry.

Bilibili schedules board meeting for Q3 2026 results approval

Bilibili Inc. announces board meeting on November 24, 2026, to approve Q3 2026 financial results, highlighting its commitment to transparency.

Arvinas reports Q3 results with updates on collaborations

Arvinas, Inc. releases its Q3 2026 report, highlighting financial performance and collaborations with Pfizer and Rigel Pharmaceuticals.

Nurix Therapeutics announces Sanofi halting SAR448272 trial

Nurix Therapeutics faces a setback as Sanofi discontinues its SAR448272 clinical trial, impacting future milestone payments and collaboration strategy.

Manitowoc Company reports Q3 2026 earnings results

Manitowoc Company announces its Q3 2026 earnings, highlighting key financial metrics and implications for the construction machinery industry.

Transcat Reports Strong Q2 Results with Revenue Growth

Transcat Inc. announces strong Q2 fiscal 2027 results, showcasing significant revenue growth and margin expansion, indicating robust performance in the testing instruments industry.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →